Connect with us

Business

'The individual was likely infectious:' Officials warn of possible COVID-19 exposure at North Battleford Walmart – CTV News Saskatoon

Published

on


NORTH BATTLEFORD —
Health officials are warning people of a possible coronavirus exposure at the North Battleford Walmart.

The Saskatchewan Health Authority said a person who tested positive for COVID-19 visited the store when “the individual was likely infectious,” according to a news release.

Officials are advising people who were at Walmart on May 21, between 12 p.m. and 2 p.m. to immediately self-isolate if they have symptoms of the virus, and call the 811 health line to arrange for testing.

People who aren’t showing symptoms, but were at the store during this time period, should self-monitor for symptoms of COVID-19 until June 5.

Symptoms of the virus include fever, dry cough, fatigue and shortness of breath.

Let’s block ads! (Why?)



Source link

Business

Another Vancouver strip club reports possible coronavirus case

Published

on

After recently notifying the public about potential coronavirus exposure at Brandi’s Show Lounge, Vancouver Coastal Health issued a COVID-19 exposure to recent patrons of another Vancouver strip club – this time the No.5 Orange.

In a statement on Tuesday afternoon, health officials said they are notifying patrons who visited the venue at 205 Main Street in the “evening hours” on Canada Day, that “an individual who tested positive for COVID-19 attended No5 Orange on that date.”

They note, however, that “there is no known risk to anyone who attended the No.5 Orange outside that date [and] there is no ongoing risk to the community.”

There is also “no evidence” that this exposure is linked to recent ones at Brandi’s Exotic Show Lounge or the Hotel Belmont.

Still, as a precaution, health officials are advising people who attended the No. 5 Orange on July 1 to monitor themselves for 14 days.

“As long as they remain healthy and do not develop symptoms, there is no need to self-isolate and they should continue with their usual daily activities,” officials said.

For those with no symptoms, “testing is not recommended because it is not accurate or useful.” However, anyone who does develop symptoms should “seek testing and immediately self-isolate.”

 

Source:| News – Daily Hive

Source link

Continue Reading

Business

Canadian company to collaborate on potential coronavirus vaccine with GSK – Global News

Published

on


The world’s largest vaccine-maker GSK has put its vaccine booster technology to work in a potential new COVID-19 shot, to be developed with a Canadian biopharmaceutical company backed by tobacco company Philip Morris.

Rather than developing its own vaccine in the global race to combat the pandemic, GSK has instead focused on contributing its adjuvant technology to at least seven other global companies, including Sanofi and China’s Clover.

READ MORE: Canadian company announces COVID-19 vaccine candidate

The latest deal, with Canadian firm Medicago, uses plant-based technology that differs from GSK’s other coronavirus-partnerships and boosts the London-listed company’s chances of finding a successful candidate and scaling production relatively quickly.

There are no approved vaccines for the respiratory illness caused by the new coronavirus, but 19 vaccines are being trialed in humans globally and some treatments, such as Gilead’s remdesivir, have been approved in certain regions.

Story continues below advertisement






5:09
When will a COVID-19 vaccine be ready?


When will a COVID-19 vaccine be ready?

Medicago’s approach, already used in a flu vaccine awaiting Canadian approval, takes the leaves of a plant as bioreactors to produce one of the three spike proteins of the novel coronavirus, the S-spike, which can be then used in the vaccine with GSK’s adjuvant.

[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]

GSK said on Tuesday the companies aimed to make their vaccine available in the first half of next year and produce about 100 million doses by the end of 2021. An early-stage human trial of three different dosage levels is expected to begin in mid-July.

Adjuvants, or efficacy boosters, are added to some vaccines to increase the immune response with the aim of achieving more lasting immunity against an infection.

READ MORE: The race for a vaccine — China leads the way in a potential coronavirus treatment

Medicago, headquartered in Quebec City, Canada, is privately owned. PMI has a 33% stake, and Mitsubishi Tanabe Pharma holds the remainder.

Story continues below advertisement

PMI has said it is evaluating options for its stake in Medicago. It was not immediately available for further comment.

© 2020 Reuters

Let’s block ads! (Why?)



Source link

Continue Reading

Business

EIA Raises Brent Crude Oil Price Outlook – OilPrice.com

Published

on



EIA Raises Brent Crude Oil Price Outlook | OilPrice.com

Julianne Geiger

Julianne Geiger is a veteran editor, writer and researcher for Oilprice.com, and a member of the Creative Professionals Networking Group.

More Info

Related News

Barrels

The Energy Information Administration raised its price outlook for Brent crude to $41 per barrel for the second half of 2020—this is $4 per barrel higher than the EIA’s forecast last month.

In its Short-Term Energy Outlook (STEs expectation that global oil inventories will continue to decline in the second half of the year and throughout next year.

“EIA expects high inventory levels and surplus crude oil production capacity will limit upward price pressures in the coming months, but as inventories decline into 2021, those upward price pressures will increase,” the EIA said in a summary of its monthly report.

Specifically, the EIA is forecasting that global liquid fuel inventories will rise at a rate of 6.7 million bpd in H1 2020, and then decline at a rate of 3.3 million bpd in H2 2020. Finally, in 2021, the EIA expects that inventories will decline further by 1.1 million bpd.

The EIA expects U.S. oil production to fall this year and next, with WTI prices sitting below $50 per barrel through next year. The EIA’s expectation is that oil production in the United States will average 11.6 million barrels per day this year, and 11.0 million bpd next year. This is off from an average of 12.2 million bpd last year. The EIA expects U.S. liquid fuels consumption to fall this year by an average of 2.1 million bpd from 2019, to 18.3 million bpd.

The EIA cautions, however, that this month’s projections for U.S. oil production were made prior to the court-ordered closure of the Dakota Access Pipeline. Energy Transfer Partners plans to file a motion to stay that decision.

By Julianne Geiger for Oilprice.com

More Top Reads From Oilprice.com:

Join the discussion | Back to homepage

Related posts

Let’s block ads! (Why?)



Source link

Continue Reading

Trending